Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06283251 · ClinicalTrials.gov registry record · NA

PediRISE Feasibility

A NA study of Pediatric Cancer and Financial Stress, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
4
Study locations

NCT06283251 is a NA study of Pediatric Cancer and Financial Stress that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 40 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06283251, a NA study of Pediatric Cancer and Financial Stress, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
4
Study locations

Study Summary

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Interventions

  • BEHAVIORAL PediRISE Resource Program

Study Locations (4)

Massachusetts

  • Boston Children's Hospital - Boston
  • Dana Farber Cancer Institute - Boston

California

  • University of California San Francisco - San Francisco

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-05-15
Est. Completion 2027-06-30
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT06283251

The ClinicalTrials.gov registry entry for NCT06283251 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which PediRISE Resource Program is the first listed.

NCT06283251 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, California, New York.

Frequently Asked Questions

What is clinical trial NCT06283251 about?

NCT06283251 is a clinical study titled "PediRISE Feasibility". The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50...

What is the current status of trial NCT06283251?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-05-15. Estimated completion is 2027-06-30.

What conditions does trial NCT06283251 study?

This clinical trial studies the following conditions: Pediatric Cancer, Financial Stress, Financial Hardship, Disparities.

What interventions are being tested in trial NCT06283251?

The interventions under investigation include: PediRISE Resource Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06283251?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06283251 being conducted?

This trial has 4 study locations across California, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.